RAFFA WEALTH MANAGEMENT, LLC’s Teva Pharmaceuticals TEVA Stock Holding History

RAFFA WEALTH MANAGEMENT, LLC’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.29K	Hold	38	–	–	﹤0.01%	943
2026 Q1	$1.15K	Hold	38	–	–	﹤0.01%	910
2025 Q4	$1.19K	Sell	38 -19	-33%	-$468	﹤0.01%	892
2025 Q3	$1.15K	Hold	57	–	–	﹤0.01%	856
2025 Q2	$955	Hold	57	–	–	﹤0.01%	881
2025 Q1	$876	Hold	57	–	–	﹤0.01%	862
2024 Q4	$1.26K	Hold	57	–	–	﹤0.01%	805
2024 Q3	$1.03K	Hold	57	–	–	﹤0.01%	837
2024 Q2	$926	Buy	+57	New	+$878	﹤0.01%	921
2021 Q1	–	Sell	-90	Closed	-$869	–	1112
2020 Q4	$869	Hold	90	–	–	﹤0.01%	770
2020 Q3	$811	Hold	90	–	–	﹤0.01%	726
2020 Q2	$1.11K	Hold	90	–	–	﹤0.01%	635
2020 Q1	$808	Hold	90	–	–	﹤0.01%	645
2019 Q4	$882	Hold	90	–	–	﹤0.01%	657
2019 Q3	$619	Buy	+90	New	+$690	﹤0.01%	696
2019 Q2	–	Sell	-90	Closed	-$1.41K	–	1315
2019 Q1	$1.41K	Sell	90 -70	-44%	-$1.23K	﹤0.01%	438
2018 Q4	$2.47K	Sell	160 -180	-53%	-$3.69K	﹤0.01%	323
2018 Q3	$7.32K	Hold	340	–	–	﹤0.01%	236
2018 Q2	$8.27K	Hold	340	–	–	﹤0.01%	216
2018 Q1	$5.81K	Hold	340	–	–	﹤0.01%	236
2017 Q4	$6.44K	Hold	340	–	–	﹤0.01%	208
2017 Q3	$5.98K	Sell	340 -150	-31%	-$3.38K	﹤0.01%	225
2017 Q2	$16.3K	Hold	490	–	–	0.01%	177
2017 Q1	$15.7K	Sell	490 -39	-7%	-$1.33K	0.01%	154
2016 Q4	$19.2K	Buy	529 +13	+3%	+$519	0.01%	149
2016 Q3	$23.7K	Sell	516 -100	-16%	-$5.22K	0.01%	131
2016 Q2	$30.9K	Buy	616 +255	+71%	+$13.6K	0.02%	111
2016 Q1	$19.3K	Hold	361	–	–	0.01%	147
2015 Q4	$23.7K	Hold	361	–	–	0.01%	126
2015 Q3	$20.4K	Hold	361	–	–	0.01%	133
2015 Q2	$21.3K	Hold	361	–	–	0.01%	132
2015 Q1	$22.5K	Sell	361 -148	-29%	-$8.61K	0.01%	116
2014 Q4	$29.3K	Buy	509 +148	+41%	+$8.25K	0.02%	104
2014 Q3	$19.4K	Buy	361 +21	+6%	+$1.11K	0.01%	114
2014 Q2	$17.8K	Hold	340	–	–	0.01%	117
2014 Q1	$18K	Sell	340 -169	-33%	-$7.81K	0.01%	113
2013 Q4	$29.3K	Buy	+509	New	+$20K	0.02%	104

Other funds holding TEVA

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

UBP

Union Bancaire Privee Geneva 1, Switzerland $9.16B AUM 31.4% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

SCM

Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return

IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

RAFFA WEALTH MANAGEMENT, LLC's TEVA Position: Q2 2026 in Review

RAFFA WEALTH MANAGEMENT, LLC held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 38 shares worth $1.29K. The position accounts for ﹤0.01% of the portfolio, ranked #943.

RAFFA WEALTH MANAGEMENT, LLC first reported a position in TEVA in Q4 2013 and has held it in 37 quarters since. The position peaked at $30.9K in Q2 2016. 183 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

RAFFA WEALTH MANAGEMENT, LLC held 38 shares of Teva Pharmaceuticals worth $1.29K as of Q2 2026.
RAFFA WEALTH MANAGEMENT, LLC left its Teva Pharmaceuticals share count unchanged in Q2 2026.
Teva Pharmaceuticals made up ﹤0.01% of RAFFA WEALTH MANAGEMENT, LLC's portfolio in Q2 2026, its #943 holding.
RAFFA WEALTH MANAGEMENT, LLC first reported a position in Teva Pharmaceuticals in Q4 2013 and has held it in 37 quarters since.
RAFFA WEALTH MANAGEMENT, LLC's Teva Pharmaceuticals position peaked at $30.9K in Q2 2016.
183 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q2 2026, filed 27 Jul 2026.